Bavarian Nordic A/S at TD Cowen Health Care Conference Transcript
Host Bavarian Nordic, and with us is Paul Chaplin, the CEO of Bavarian Nordic. Paul, thanks for joining.
/-&
Thank you.
Questions & Answers
So it's been certainly a very eventful year for you guys in the orthopox biodefense side of things. Maybe let's start our discussion with JYNNEOS. Can you discuss a little bit of the background of JYNNEOS? How it was developed, and more importantly, how it differs from ACAM2000?
/-&
Yeah. So MBA of JYNNEOS as a vaccine is made out of -- is a live viral vector. At the time back in the turn of the 2000s, there were traditional smallpox vaccines like ACAM available. They have serious side effects and even the immune compromised really shouldn't be vaccinated.
So at a time when governments
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
